144 related articles for article (PubMed ID: 33748729)
1. Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States.
de Avila V; Paik JM; de Avila L; Henry L; Mohess D; Roche-Green A; Younossi ZM
JHEP Rep; 2021 Apr; 3(2):100236. PubMed ID: 33748729
[TBL] [Abstract][Full Text] [Related]
2. Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
Fukui N; Golabi P; Otgonsuren M; Mishra A; Venkatesan C; Younossi ZM
Am J Gastroenterol; 2017 Nov; 112(11):1700-1708. PubMed ID: 29016566
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia.
Lin PJ; Zhu Y; Olchanski N; Cohen JT; Neumann PJ; Faul JD; Fillit HM; Freund KM
JAMA Netw Open; 2022 Jun; 5(6):e2216260. PubMed ID: 35679046
[TBL] [Abstract][Full Text] [Related]
4. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
[TBL] [Abstract][Full Text] [Related]
5. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Long-term Mortality and Patterns of End-of-Life Care Among Medicare Sepsis Survivors Discharged to Home Health Care.
Courtright KR; Jordan L; Murtaugh CM; Barrón Y; Deb P; Moore S; Bowles KH; Mikkelsen ME
JAMA Netw Open; 2020 Feb; 3(2):e200038. PubMed ID: 32101307
[TBL] [Abstract][Full Text] [Related]
7. Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.
Fukui N; Golabi P; Otgonsuren M; de Avila L; Bush H; Younossi ZM
Aliment Pharmacol Ther; 2018 Mar; 47(5):680-688. PubMed ID: 29314093
[TBL] [Abstract][Full Text] [Related]
8. Hospice Utilization and Its Effect on Acute Care Needs at the End of Life in Medicare Beneficiaries With Hepatocellular Carcinoma.
Sanoff HK; Chang Y; Reimers M; Lund JL
J Oncol Pract; 2017 Mar; 13(3):e197-e206. PubMed ID: 28029300
[TBL] [Abstract][Full Text] [Related]
9. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
10. Emergency Care Use and the Medicare Hospice Benefit for Individuals with Cancer with a Poor Prognosis.
Obermeyer Z; Clarke AC; Makar M; Schuur JD; Cutler DM
J Am Geriatr Soc; 2016 Feb; 64(2):323-9. PubMed ID: 26805592
[TBL] [Abstract][Full Text] [Related]
11. End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma.
Rice DR; Hyer JM; Diaz A; Pawlik TM
Ann Surg Oncol; 2021 Sep; 28(9):5414-5422. PubMed ID: 33528708
[TBL] [Abstract][Full Text] [Related]
12. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease.
Chettiar A; Montez-Rath M; Liu S; Hall YN; O'Hare AM; Kurella Tamura M
Clin J Am Soc Nephrol; 2018 Aug; 13(8):1180-1187. PubMed ID: 30026286
[TBL] [Abstract][Full Text] [Related]
13. Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
Williamson KD; Gill MG; Andrews JM; Harley HA
Intern Med J; 2016 Dec; 46(12):1407-1413. PubMed ID: 27643595
[TBL] [Abstract][Full Text] [Related]
14. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
Zuckerman RB; Stearns SC; Sheingold SH
J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
[TBL] [Abstract][Full Text] [Related]
15. Family Perspectives on Aggressive Cancer Care Near the End of Life.
Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
[TBL] [Abstract][Full Text] [Related]
16. Inequity in end-of-life care for patients with chronic liver disease in England.
Woodland H; Buchanan RM; Pring A; Dancox M; McCune A; Forbes K; Verne J
Liver Int; 2023 Nov; 43(11):2393-2403. PubMed ID: 37519025
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
Chiang JK; Kao YH; Lai NS
PLoS One; 2015; 10(9):e0138773. PubMed ID: 26406871
[TBL] [Abstract][Full Text] [Related]
18. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients.
C Gordon S; Fraysse J; Li S; Ozbay AB; Wong RJ
Am J Gastroenterol; 2020 Apr; 115(4):562-574. PubMed ID: 31833859
[TBL] [Abstract][Full Text] [Related]
19. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
Zou WY; El-Serag HB; Sada YH; Temple SL; Sansgiry S; Kanwal F; Davila JA
Dig Dis Sci; 2018 May; 63(5):1173-1181. PubMed ID: 29508165
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
